Condition:   Advanced or Metastatic Solid Malignancies
Interventions:   Drug: Sitravatinib;   Drug: Nivolumab;   Drug: Pembrolizumab;   Drug: Enfortumab Vedotin-Ejfv;   Drug: Ipilimumab
Sponsor:   Mirati Therapeutics Inc.
Recruiting